BindingDB logo
myBDB logout

BDBM50433041 CHEMBL2375960::US8633204, 306

SMILES: Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cnn(C)c1

InChI Key: InChIKey=LOYNAYXFINASCA-OKILXGFUSA-N

Data: 2 KI  2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50433041   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3K alpha)


(Mus musculus (Mouse))
BDBM50433041
PNG
(CHEMBL2375960 | US8633204, 306)
Show SMILES Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cnn(C)c1 |r,wD:8.7,11.14,(54.57,-30.85,;54.57,-32.39,;53.24,-33.16,;53.24,-34.71,;51.91,-35.48,;54.58,-35.48,;55.9,-34.71,;57.24,-35.49,;57.24,-37.03,;58.57,-37.79,;58.56,-39.34,;57.22,-40.1,;55.89,-39.32,;55.9,-37.79,;57.21,-41.64,;55.87,-42.4,;54.54,-41.63,;53.2,-42.39,;54.55,-40.09,;58.59,-34.72,;59.92,-35.49,;58.59,-33.16,;57.25,-32.38,;55.91,-33.16,;59.93,-32.4,;61.32,-33.04,;62.36,-31.91,;61.61,-30.57,;62.24,-29.17,;60.1,-30.88,)|
Show InChI InChI=1S/C20H25N7O3/c1-11-15-7-16(12-8-23-26(2)9-12)19(29)27(18(15)25-20(22)24-11)13-3-5-14(6-4-13)30-10-17(21)28/h7-9,13-14H,3-6,10H2,1-2H3,(H2,21,28)(H2,22,24,25)/t13-,14+
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
25n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of mouse PI3Kalpha


Bioorg Med Chem Lett 23: 2787-92 (2013)


Article DOI: 10.1016/j.bmcl.2013.02.020
BindingDB Entry DOI: 10.7270/Q2NZ890X
More data for this
Ligand-Target Pair
Serine/threonine-protein kinase mTOR


(Homo sapiens (Human))
BDBM50433041
PNG
(CHEMBL2375960 | US8633204, 306)
Show SMILES Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cnn(C)c1 |r,wD:8.7,11.14,(54.57,-30.85,;54.57,-32.39,;53.24,-33.16,;53.24,-34.71,;51.91,-35.48,;54.58,-35.48,;55.9,-34.71,;57.24,-35.49,;57.24,-37.03,;58.57,-37.79,;58.56,-39.34,;57.22,-40.1,;55.89,-39.32,;55.9,-37.79,;57.21,-41.64,;55.87,-42.4,;54.54,-41.63,;53.2,-42.39,;54.55,-40.09,;58.59,-34.72,;59.92,-35.49,;58.59,-33.16,;57.25,-32.38,;55.91,-33.16,;59.93,-32.4,;61.32,-33.04,;62.36,-31.91,;61.61,-30.57,;62.24,-29.17,;60.1,-30.88,)|
Show InChI InChI=1S/C20H25N7O3/c1-11-15-7-16(12-8-23-26(2)9-12)19(29)27(18(15)25-20(22)24-11)13-3-5-14(6-4-13)30-10-17(21)28/h7-9,13-14H,3-6,10H2,1-2H3,(H2,21,28)(H2,22,24,25)/t13-,14+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
93n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of mTOR (unknown origin)


Bioorg Med Chem Lett 23: 2787-92 (2013)


Article DOI: 10.1016/j.bmcl.2013.02.020
BindingDB Entry DOI: 10.7270/Q2NZ890X
More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform


(Homo sapiens (Human))
BDBM50433041
PNG
(CHEMBL2375960 | US8633204, 306)
Show SMILES Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cnn(C)c1 |r,wD:8.7,11.14,(54.57,-30.85,;54.57,-32.39,;53.24,-33.16,;53.24,-34.71,;51.91,-35.48,;54.58,-35.48,;55.9,-34.71,;57.24,-35.49,;57.24,-37.03,;58.57,-37.79,;58.56,-39.34,;57.22,-40.1,;55.89,-39.32,;55.9,-37.79,;57.21,-41.64,;55.87,-42.4,;54.54,-41.63,;53.2,-42.39,;54.55,-40.09,;58.59,-34.72,;59.92,-35.49,;58.59,-33.16,;57.25,-32.38,;55.91,-33.16,;59.93,-32.4,;61.32,-33.04,;62.36,-31.91,;61.61,-30.57,;62.24,-29.17,;60.1,-30.88,)|
Show InChI InChI=1S/C20H25N7O3/c1-11-15-7-16(12-8-23-26(2)9-12)19(29)27(18(15)25-20(22)24-11)13-3-5-14(6-4-13)30-10-17(21)28/h7-9,13-14H,3-6,10H2,1-2H3,(H2,21,28)(H2,22,24,25)/t13-,14+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 58.1n/an/an/an/a7.425



Pfizer Inc.

US Patent


Assay Description
Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...


US Patent US8633204 (2014)


BindingDB Entry DOI: 10.7270/Q2Q81BQT
More data for this
Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase


(Homo sapiens (Human))
BDBM50433041
PNG
(CHEMBL2375960 | US8633204, 306)
Show SMILES Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cnn(C)c1 |r,wD:8.7,11.14,(54.57,-30.85,;54.57,-32.39,;53.24,-33.16,;53.24,-34.71,;51.91,-35.48,;54.58,-35.48,;55.9,-34.71,;57.24,-35.49,;57.24,-37.03,;58.57,-37.79,;58.56,-39.34,;57.22,-40.1,;55.89,-39.32,;55.9,-37.79,;57.21,-41.64,;55.87,-42.4,;54.54,-41.63,;53.2,-42.39,;54.55,-40.09,;58.59,-34.72,;59.92,-35.49,;58.59,-33.16,;57.25,-32.38,;55.91,-33.16,;59.93,-32.4,;61.32,-33.04,;62.36,-31.91,;61.61,-30.57,;62.24,-29.17,;60.1,-30.88,)|
Show InChI InChI=1S/C20H25N7O3/c1-11-15-7-16(12-8-23-26(2)9-12)19(29)27(18(15)25-20(22)24-11)13-3-5-14(6-4-13)30-10-17(21)28/h7-9,13-14H,3-6,10H2,1-2H3,(H2,21,28)(H2,22,24,25)/t13-,14+
PDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 988n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells


Bioorg Med Chem Lett 23: 2787-92 (2013)


Article DOI: 10.1016/j.bmcl.2013.02.020
BindingDB Entry DOI: 10.7270/Q2NZ890X
More data for this
Ligand-Target Pair